|
|
Article: HCV therapy with IFN/RBV relatively safe in patients coinfected with HIV and HCV.
- Article from:
- Obesity, Fitness & Wellness Week
- Article date:
- June 12, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JUN 12 - (NewsRx.com & NewsRx.net) -- HCV therapy with interferon plus ribovarin is relatively safe in patients coinfected with HIV and HCV.
According to a study from the American Foundation for AIDS Research, "Human immunodeficiency virus (HIV)-infected patients increasingly experience the consequences of chronic hepatitis C virus (HCV) coinfection. This trial randomized 107 patients coinfected with HIV and HCV to receive 48 weeks of interferon alfa-2b (IFN) 3 million units three times weekly plus either a full course of ribavirin (RBV) at 800 mg/day (group A, n = 53) or 16 weeks of placebo, followed by RBV (group B; n = 54)."
"The primary ...